Literature DB >> 1847382

Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.

S C Head1, M A Karmali, C A Lingwood.   

Abstract

Verocytotoxins comprise a family of closely related subunit proteins. Two members of this group, VT1 and the immunologically distinct VT2, have been found to share similar physical properties, and yet several differences in their biological activities have been noted. The subunits of these toxins were separated using urea and isolated by high performance liquid chromatography gel filtration. Reconstituted VT1 and VT2 as well as VT1-A:VT2-B and VT2-A:VT1-B hybrid toxins were then prepared. The B subunit was found to determine cell culture specificity, cytotoxic titer, and antibody neutralizability as determined on Vero and MRC-5 cells. Cross-linking isolated B chains revealed 5 species upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis for both VT1-B and VT2-B. Using an in vitro translation system, both toxin A subunits inhibited protein synthesis at concentrations as low as 4 pM. In glycolipid binding assays, VT1 and VT1-B subunits competed equally on a molar basis with 125I-VT1 for the receptor, globotriaosylceramide, however, a 1000-fold excess of VT2 was required. Ligand analysis of direct VT1 and VT2 receptor binding assays revealed a difference in binding affinity constants (Kd of VT1 = 4.6 x 10(-8) M; VT2 = 3.7 x 10(-7) M).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847382

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer.

Authors:  Paola Marcato; Kathleen Vander Helm; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.

Authors:  Rong Di; Eric Kyu; Varsha Shete; Hemalatha Saidasan; Peter C Kahn; Nilgun E Tumer
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

3.  Neutral red assay for measurement of quantitative vero cell cytotoxicity.

Authors:  A Valdivieso-Garcia; R C Clarke; K Rahn; A Durette; D L Macleod; C L Gyles
Journal:  Appl Environ Microbiol       Date:  1993-06       Impact factor: 4.792

4.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

5.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

6.  Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.

Authors:  D Reymond; M A Karmali; I Clarke; M Winkler; M Petric
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

7.  Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.

Authors:  S Arab; M Murakami; P Dirks; B Boyd; S L Hubbard; C A Lingwood; J T Rutka
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

8.  Instability of toxin A subunit of AB(5) toxins in the bacterial periplasm caused by deficiency of their cognate B subunits.

Authors:  Sang-Hyun Kim; Su Hyang Ryu; Sang-Ho Lee; Yong-Hoon Lee; Sang-Rae Lee; Jae-Won Huh; Sun-Uk Kim; Ekyune Kim; Sunghyun Kim; Sangyong Jon; Russell E Bishop; Kyu-Tae Chang
Journal:  Biochim Biophys Acta       Date:  2011-07-05

Review 9.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Authors:  Richard L Siegler; Tom G Obrig; Theodore J Pysher; Vernon L Tesh; Nathaniel D Denkers; Fletcher B Taylor
Journal:  Pediatr Nephrol       Date:  2003-01-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.